chr6-36684194-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1
The NM_000389.5(CDKN1A):c.93C>A(p.Ser31Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0989 in 1,611,622 control chromosomes in the GnomAD database, including 14,561 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.15 ( 2560 hom., cov: 32)
Exomes 𝑓: 0.094 ( 12001 hom. )
Consequence
CDKN1A
NM_000389.5 missense
NM_000389.5 missense
Scores
18
Clinical Significance
Conservation
PhyloP100: 0.899
Genes affected
CDKN1A (HGNC:1784): (cyclin dependent kinase inhibitor 1A) This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-cyclin-dependent kinase2 or -cyclin-dependent kinase4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen, a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of cyclin-dependent kinase2, and may be instrumental in the execution of apoptosis following caspase activation. Mice that lack this gene have the ability to regenerate damaged or missing tissue. Multiple alternatively spliced variants have been found for this gene. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=2.681613E-4).
BP6
Variant 6-36684194-C-A is Benign according to our data. Variant chr6-36684194-C-A is described in ClinVar as [Benign]. Clinvar id is 17565.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr6-36684194-C-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.471 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDKN1A | NM_000389.5 | c.93C>A | p.Ser31Arg | missense_variant | 2/3 | ENST00000244741.10 | NP_000380.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDKN1A | ENST00000244741.10 | c.93C>A | p.Ser31Arg | missense_variant | 2/3 | 1 | NM_000389.5 | ENSP00000244741 | P1 |
Frequencies
GnomAD3 genomes AF: 0.149 AC: 22686AN: 152110Hom.: 2560 Cov.: 32
GnomAD3 genomes
AF:
AC:
22686
AN:
152110
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.154 AC: 38469AN: 249318Hom.: 5612 AF XY: 0.140 AC XY: 18941AN XY: 134984
GnomAD3 exomes
AF:
AC:
38469
AN:
249318
Hom.:
AF XY:
AC XY:
18941
AN XY:
134984
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0937 AC: 136706AN: 1459394Hom.: 12001 Cov.: 33 AF XY: 0.0924 AC XY: 67077AN XY: 726132
GnomAD4 exome
AF:
AC:
136706
AN:
1459394
Hom.:
Cov.:
33
AF XY:
AC XY:
67077
AN XY:
726132
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.149 AC: 22716AN: 152228Hom.: 2560 Cov.: 32 AF XY: 0.153 AC XY: 11402AN XY: 74430
GnomAD4 genome
AF:
AC:
22716
AN:
152228
Hom.:
Cov.:
32
AF XY:
AC XY:
11402
AN XY:
74430
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
267
ALSPAC
AF:
AC:
258
ESP6500AA
AF:
AC:
1057
ESP6500EA
AF:
AC:
602
ExAC
AF:
AC:
17769
Asia WGS
AF:
AC:
897
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
CIP1/WAF1 TUMOR-ASSOCIATED POLYMORPHISM 1 Benign:1
Benign, no assertion criteria provided | literature only | OMIM | Jul 01, 1996 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T;T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;T;.;.;.
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;N;N;N
MutationTaster
Benign
P;P;P;P;P
PrimateAI
Benign
T
PROVEAN
Benign
.;.;N;N;N
REVEL
Benign
Sift
Benign
.;.;T;T;T
Sift4G
Benign
T;T;T;T;T
Polyphen
B;B;B;B;B
Vest4
MutPred
Gain of solvent accessibility (P = 0.0766);Gain of solvent accessibility (P = 0.0766);Gain of solvent accessibility (P = 0.0766);Gain of solvent accessibility (P = 0.0766);Gain of solvent accessibility (P = 0.0766);
MPC
0.19
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at